Related references
Note: Only part of the references are listed.Intestinal overexpression of IL-18 promotes eosinophils-mediated allergic disorders
Alok K. Verma et al.
IMMUNOLOGY (2019)
Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1β and IL-18
Daniela Impellizzeri et al.
BIOCHEMICAL PHARMACOLOGY (2018)
HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation
Ossama Allam et al.
PLOS ONE (2018)
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Loris R. Lopetuso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease
Hazel Tye et al.
NATURE COMMUNICATIONS (2018)
Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis
Christina L. Hayes et al.
SCIENTIFIC REPORTS (2018)
Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice
Tomoyuki Oshio et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice
Mingyuan Han et al.
JOURNAL OF IMMUNOLOGY (2017)
IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice
Rongguo He et al.
MOLECULAR IMMUNOLOGY (2017)
IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis
Lei Tu et al.
ONCOTARGET (2017)
NLRP6 Protects II10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Sergey S. Seregin et al.
CELL REPORTS (2017)
Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation
Andrea C. Lei-Leston et al.
FRONTIERS IN IMMUNOLOGY (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis
Carlo De Salvo et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis
Ankit Malik et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing
Gregory D. Rak et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair
Chandramohan Natarajan et al.
PLOS ONE (2016)
Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
Maayan Levy et al.
CELL (2015)
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Roni Nowarski et al.
CELL (2015)
SAMP1/YitFc Mice Develop Ileitis via Loss of CCL21 and Defects in Dendritic Cell Migration
Zbigniew Mikulski et al.
GASTROENTEROLOGY (2015)
Interleukin-22 Induces Interleukin-18 Expression from Epithelial Cells during Intestinal Infection
Melba Munoz et al.
IMMUNITY (2015)
IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions
Laurel A. Monticelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interleukin-18 genetic polymorphisms contribute differentially to the susceptibility to Crohn's disease
Su-Jun Gao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Targeted inhibition of IL-18 attenuates irinotecaninduced intestinal mucositis in mice
R. C. P. Lima-Junior et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion
Marta Wlodarska et al.
CELL (2014)
Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
Juliana Bessa et al.
JOURNAL OF AUTOIMMUNITY (2014)
IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut
Susanne Sattler et al.
JOURNAL OF AUTOIMMUNITY (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability
Tamia K. Lapointe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation
Yeon-Sook Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
IL-33 attenuates development and perpetuation of chronic intestinal inflammation
Philipp Gross et al.
INFLAMMATORY BOWEL DISEASES (2012)
Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice
Lihua Duan et al.
MOLECULAR MEDICINE (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
TREATMENT WITH INTERLEUKIN-18 BINDING PROTEIN AMELIORATES TOXOPLASMA GONDII-INDUCED SMALL INTESTINAL PATHOLOGY THAT IS INDUCED BY BONE MARROW CELL-DERIVED INTERLEUKIN-18
D. Struck et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2012)
Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
Sarah L. Kempster et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Eran Elinav et al.
CELL (2011)
Lack of association of interleukin-18 gene promoter-607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis
H-F Pan et al.
LUPUS (2011)
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
Jon Sponheim et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
ST2 Negatively Regulates TLR2 Signaling, but Is Not Required for Bacterial Lipoprotein-Induced Tolerance
Jinghua Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
Cutting edge:: Priming of NK cells by IL-18
Julie Chaix et al.
JOURNAL OF IMMUNOLOGY (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
The interleukin-1β-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation
F Loher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage
PV Sivakumar et al.
GUT (2002)
Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production
B Siegmund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)